AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21214352
Drug: Cooling collar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooling collar (CC)
Trial: 18342185
Drug: Trospium 60
RxNorm normalized name: trospium 60 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trospium 60 mg QD
Trial: 16540862
Drug: Chiropractic care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic care without physical therapy or modalities
Trial: 16540862
Drug: Medical care
RxNorm normalized name: benzethonium Medicated Liquid Soap [Bedside-Care]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical care with physical therapy
Trial: 16540862
Drug: Chiropractic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic and physical therapy
Trial: 12653262
Drug: Tacrolimus and
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus and low-dose prednisolone
Trial: 1347204
Drug: Pipecuronium 0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pipecuronium 0.06 mg.kg-1
Trial: 1347205
Drug: Vecuronium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.2 mg.kg-1
Trial: 29789925
Drug: CYP2D6 gene
RxNorm normalized name: Immature cell growth-inhibiting gene 1 protein
DrugBank: Cerliponase alfa (DB13173)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: CYP2D6 gene rs28371725 CC and CT genotypes in PPE
Trial: 23217093
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (augmented by recommendation for counseling center and physician information)
Trial: 16394300
Drug: Intravenous paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel
Trial: 16394300
Drug: Intravenous paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous paclitaxel plus cisplatin
Trial: 10848537
Drug: Glibenclamide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (5 mg po)
Trial: 10848537
Drug: Insulin (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (0.3 mU.kg(‐1).min(‐1) iv)
Trial: 10848537
Drug: Nicorandil (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (40 mg)
Trial: 10848537
Drug: Glibenclamide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (5 mg) or Nicorandil (40 mg) or Glibenclamide and Nicorandil
Trial: 8869800
Drug: Prophylactic or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic or pre‐emptive therapy
Trial: 8869800
Drug: Empiric therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric therapy for febrile episodes
Trial: 8869800
Drug: Pre‐emptive therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐emptive therapy
Trial: 1323974
Drug: Recombinant interferon
RxNorm normalized name: Recombinant Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant interferon beta serine (12 x 10(6) U, nasal drops, three times daily for 4.3 days)
Trial: 1323974
Drug: Placebo (nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (nasal drops, three times daily for 4.3 days)
Trial: 29775959
Drug: Cigarettes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarettes with 15.8 mg/g nicotine
Trial: 29775959
Drug: Cigarettes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarettes with 5.2 mg/g nicotine
Trial: 29775959
Drug: Cigarettes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarettes with 1.3 mg/g nicotine
Trial: 29775959
Drug: Cigarettes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarettes with 0.4 mg/g nicotine
Trial: 22824768
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation and anti-H. pylori therapy (Group I)
Trial: 14613288
Drug: Etanercept 25
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 25 mg subcutaneously twice weekly for 24 weeks
Trial: 9659650
Drug: Carbetocin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbetocin (100 micrograms intravenous injection)
Trial: 9659650
Drug: Oxytocin (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin (continuous 16 hour infusion)
Trial: 2534405
Drug: D-sulpiride at
RxNorm normalized name: sulpiride
DrugBank: Sulpiride (DB00391)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-sulpiride at 0.05 mg/kg per min
Trial: 2534405
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic factor (ANF) + D-sulpiride at the same doses
Trial: 786773
Drug: Intravenous metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous metoclopramide (M)
Trial: 25126957
Drug: Melatonin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (6 mg daily for 40 days)
Trial: 21971959
Drug: Early stage
RxNorm normalized name: SALICYLIC ACID 0.14 mg TOPICAL PATCH [Peace Out Early Stage Acne Dot]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early stage cervical and endometrial cancer treatment
Trial: 16990976
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin (20 IU injection)
Trial: 16990976
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate ointment (300 mg of 0.2% applied three times daily for 30 days)
Trial: 8633687
Drug: Divalproex, 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divalproex, 750 mg/day for 2 days, then 1,000 mg/day on days 3-5, adjusted as clinically indicated for 21 days
Trial: 8633687
Drug: Divalproex, serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divalproex, serum levels >= 125 micrograms/ml
Trial: 1538042
Drug: Pentoxifylline (Trental)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (Trental) 400 milligram tablets three times daily
Trial: 18810239
Drug: Baseline serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline serum urate levels (measured in mg/dl)
Trial: 9033440
Drug: Bambuterol 20
RxNorm normalized name: bambuterol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 20 mg nocte (B20)
Trial: 9033440
Drug: Bambuterol 10
RxNorm normalized name: bambuterol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 10 mg nocte (B10)
Trial: 9033440
Drug: Terbutaline 3
RxNorm normalized name: terbutaline 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 3 mg t.i.d. (T)
Trial: 20689457
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution (P)
Trial: 8509565
Drug: Flosequinan (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosequinan (100 mg once daily, n = 93)
Trial: 3549837
Drug: Milrinone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milrinone (all doses)
Trial: 3549837
Drug: Milrinone (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milrinone (high dose)
Trial: 20678799
Drug: Monthly intravitreal
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly intravitreal injections of 0.5 mg ranibizumab
Trial: 20678799
Drug: 3 monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 3 monthly injections followed by dosing as needed (PRN)
Trial: 16556673
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg IN buserelin twice a day (group D)
Trial: 16556673
Drug: 10,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10,000 IU hCG followed by vaginal administration of micronized progesterone (3x 200 mg/day) (group A)
Trial: 10902992
Drug: M =
RxNorm normalized name: Methadone
DrugBank: Methadone (DB00333)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: M = 12 mg iron + 209 kJ
Trial: 8263313
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg venlafaxine
Trial: 3032828
Drug: Dietary fibre
RxNorm normalized name: Fiore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary fibre supplement of 7.3 g per day
Trial: 31429603
Drug: Asthmatic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asthmatic and diabetic patients using budesonide (up to 825 mcg)
Trial: 22350703
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg rectal diclofenac (reduced to 25 mg for patients weighing <50 kg)
Trial: 22350703
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (saline infusion without diclofenac)
Trial: 16023511
Drug: MIT therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIT therapy
Trial: 16023511
Drug: No MIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No MIT therapy
Trial: 12481892
Drug: Amifostine (AMI)
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amifostine (AMI) 910 mg/m2 in 15 min infusion preceding MEL 200 mg/m2
Trial: 9637805
Drug: Rectal diazepam
RxNorm normalized name: diazepam Rectal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal diazepam gel (0.2 to 0.5 mg/kg based on age)
Trial: 9637805
Drug: Rectal diazepam
RxNorm normalized name: diazepam Rectal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal diazepam gel
Trial: 334206
Drug: Buprenorphine 0.6
RxNorm normalized name: buprenorphine 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 0.6 mg
Trial: 31629348
Drug: CES-HGel (carbohydrate-electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CES-HGel (carbohydrate-electrolyte solution with sodium alginate and pectin)
Trial: 31629348
Drug: CES-Std (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CES-Std (standard carbohydrate-electrolyte solution)
Trial: 30222805
Drug: Ranibizumab plus
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab plus deferred laser (0.5 mg)
Trial: 30222805
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide (FAc) 0.2 μg/day
Trial: 22990933
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (control), n=15
Trial: 19859788
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior group therapy (CBT)
Trial: 18333863
Drug: Saquinavir (SQV;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir (SQV; 1200 mg t.i.d.)
Trial: 23511711
Drug: Ketoconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (400 mg q.d.)
Trial: 18333863
Drug: Ritonavir-boosted lopinavir
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted lopinavir (LPV/r; 400 mg/100 mg b.i.d.)
Trial: 18333863
Drug: Ritonavir-boosted saquinavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted saquinavir (SQV/r; 1000 mg/100 mg b.i.d.)
Trial: 18333863
Drug: Low-dose ritonavir
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ritonavir (RTV; 100 mg b.i.d.)
Trial: 18333863
Drug: Atazanavir (ATZ;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir (ATZ; 400 mg q.d.)
Trial: 18333863
Drug: Ritonavir-boosted atazanavir
RxNorm normalized name: atazanavir and ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted atazanavir (ATZ/r; 300 mg/100 mg b.i.d.)
Trial: 18333863
Drug: Ritonavir-boosted tipranavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted tipranavir (TPV/r; 500 mg/200 mg b.i.d.)
Trial: 18333862
Drug: Maraviroc (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maraviroc (100 mg b.i.d.)
Trial: 12401633
Drug: Epidural ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ropivacaine 1.5 mg/kg with epinephrine 5 microg/mL
Trial: 12401633
Drug: Epidural ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ropivacaine 1.5 mg/kg without epinephrine (plain group)
Trial: 10621575
Drug: Capital infusions
RxNorm normalized name: Lespedeza capitata flowering top extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capital infusions and up-front classes
Trial: 7546757
Drug: C6 stellate
RxNorm normalized name: HYDROGENATED C6-20 POLYOLEFIN (100 CST)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C6 stellate ganglion nerve block with radiocontrast and local anesthetic (5 ml increments to 20 ml total volume)
Trial: 7546757
Drug: C7 stellate
RxNorm normalized name: Mastocarpus stellatus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C7 stellate ganglion nerve block with radiocontrast and local anesthetic (5 ml increments to 20 ml total volume)
Trial: 2360541
Drug: 4.0 mg
RxNorm normalized name: LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.0 mg pyridoxine
Trial: 2360541
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg pyridoxine
Trial: 2360541
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg zinc
Trial: 2360541
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg zinc
Trial: 343182
Drug: Conventional practices
RxNorm normalized name: Practical Alchemy Purify and Protect Duo KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional practices (amniotomy and intravenous oxytocin infusion or oral prostaglandin therapy)
Trial: 27908604
Drug: Phospholipid liposomal
RxNorm normalized name: Egg Phospholipids
DrugBank: Egg phospholipids (DB14233)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phospholipid liposomal spray (Tears Again®) applied to one eye four times daily for two weeks.
Trial: 27908604
Drug: Control eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control eye (no treatment).
Trial: 26583954
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) - 10 sessions
Trial: 23915015
Drug: Sertraline (SER)
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline (SER) - 50-200 mg/d
Trial: 23915015
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received diabetes treatment as usual
Trial: 21995387
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard adjuvant systemic therapy without zoledronic acid)
Trial: 25935963
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg mifepristone
Trial: 19187370
Drug: 24-hour interval
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour interval to misoprostol administration
Trial: 19187370
Drug: 48-hour interval
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48-hour interval to misoprostol administration
Trial: 15186939
Drug: Ivermectin at
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin at 800 microg/kg given at 3-monthly intervals
Trial: 15186939
Drug: Ivermectin at
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin at high doses (800 microg/kg)
Trial: 19788472
Drug: Zolmitriptan 10
RxNorm normalized name: zolmitriptan 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan 10 mg
Trial: 9453273
Drug: Dexfenfluramine 15
RxNorm normalized name: dexfenfluramine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexfenfluramine 15 mg
Trial: 9453273
Drug: Lorazepam 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 1.25 mg
Trial: 7876396
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg oral dose of metronidazole
Trial: 7876396
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of 0.75% metronidazole intravaginal gel (37.5 mg metronidazole)
Trial: 31356278
Drug: FOLFOX perioperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FOLFOX perioperative chemotherapy (4 cycles before surgery and 8 cycles after)
Trial: 26780673
Drug: Individual schema
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual schema therapy (ST)
Trial: 26780673
Drug: No-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment control condition (baseline phase)
Trial: 18379232
Drug: Doripenem 500
RxNorm normalized name: doripenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doripenem 500 mg every 8 hrs via a 4‐hr intravenous infusion
Trial: 18379232
Drug: Imipenem 500
RxNorm normalized name: imipenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem 500 mg every 6 hrs or 1000 mg every 8 hrs via 30‐ or 60‐min intravenous infusions
Trial: 12789182
Drug: Dermasanding treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermasanding treatment
Trial: 10663454
Drug: MDL 100,240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDL 100,240 2.5 mg orally, q.d. for 8 days
Trial: 10663454
Drug: MDL 100,240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDL 100,240 10 mg orally, q.d. for 8 days
Trial: 10663454
Drug: MDL 100,240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDL 100,240 20 mg orally, q.d. for 8 days
Trial: 10663454
Drug: MDL 100,240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDL 100,240 (oral solution)
Trial: 8801396
Drug: Lovastatin (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (20-80 mg/day)
Trial: 6849734
Drug: Bedtime chenic
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime chenic acid 8 mg kg‐1 day‐1
Trial: 6849734
Drug: Sodium acetyl
RxNorm normalized name: sodium acetyltryptophanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium acetyl salicylate 600 mg four times daily
Trial: 6849734
Drug: Bedtime chenic
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime chenic acid 8 mg kg‐1 day‐1 plus sodium acetyl salicylate
Trial: 31399378
Drug: Inactivated varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated varicella zoster virus vaccine (VZV)
Trial: 27749141
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of haloperidol and midazolam
Trial: 22779281
Drug: Oral-B Precision
RxNorm normalized name: Precise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B Precision Clean (PC) brush head
Trial: 17929519
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading (4 months after implant insertion)
Trial: 17929519
Drug: Early loading
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early loading (1 week after implant surgery)
Trial: 11257249
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg weekly
Trial: 11257249
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg twice a week
Trial: 11257249
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg twice a week for 12 weeks followed by 30 mg weekly
Trial: 11257249
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg twice a week for 6 weeks followed by 30 mg weekly
Trial: 11257249
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg weekly
Trial: 11257249
Drug: Single 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 60 mg loading dose followed by 30 mg weekly doses
Trial: 11257249
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg weekly (Dosage regimen VI)
Trial: 11257249
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg twice a week for 12 weeks (Dosage regimen III)